“There simply is not a good solution on the market for treating respiratory diseases, and Airway Therapeutics is looking to change that. We are excited about the potential of its technology as it is focused on addressing the cause of the diseases as well as eliminating the side effects associated with many of today’s medications. Airway is taking advantage of all of the business assistance services that BIOSTART has to offer, and we are pleased to help them along the way with the connections, guidance and resources they will need to get their product into the market.”

– Carol Frankenstein, BIOSTART President